⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Michael PolydefkisM.D.

Neurology · Baltimore, MD 21287

NPI: 1194768614

Share:𝕏fin

43

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersExtreme cost outlier (population + peer)High long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

341

Total Claims

$1.8M

Drug Cost

39

Beneficiaries

$46K

Cost/Patient

Risk Score Breakdown 43/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Cost per patient outlier+10
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+2232%

Opioid rate vs peers

30.5% vs 1.3% avg

+1039%

Cost per patient vs peers

$46K vs $4,034 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

30.5%

Opioid Rate

104

Opioid Claims

$16K

Opioid Cost

52.9%

Long-Acting Rate

This provider's opioid prescribing rate of 30.5% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 236 claims · $20K

Patient Profile

72

Avg Age

56%

Female

1.76

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About